Duke Autism Study

Duke University Medical Center is conducting a Phase II Clinical Trial of cord blood infusion for children with Autism Spectrum Disorder (ASD). The goal of the Phase II study will be to determine if there is a benefit from an intravenous infusion of autologous (the child’s own) or unrelated donor cord blood to children with ASD.

To be considered for inclusion in this study:

  • Your child must have a confirmed diagnosis of Autism Spectrum Disorder 
  • Your child must be between 2-7 years of age.
  • You must be able to travel with your child to Duke University Medical Center in North Carolina, U.S. on 2 separate occasions for 4 days each, 6 months apart.
To learn more about the study and requirements for participation visit: www.clinicaltrials.gov/show/NCT02847182

If you would like to participate in the Duke study, please email Duke Study Team: DukeACTstudy@dm.duke.edu

If Duke requests your cord blood information, complete and submit the Consent to Release Information Form.